CN1150019C - Medicine for treating hecrosis of femoral head - Google Patents
Medicine for treating hecrosis of femoral head Download PDFInfo
- Publication number
- CN1150019C CN1150019C CNB01106448XA CN01106448A CN1150019C CN 1150019 C CN1150019 C CN 1150019C CN B01106448X A CNB01106448X A CN B01106448XA CN 01106448 A CN01106448 A CN 01106448A CN 1150019 C CN1150019 C CN 1150019C
- Authority
- CN
- China
- Prior art keywords
- radix
- medicine
- rhizoma
- roots
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The present invention relates to a medicine for treating femoral head necrosis, which is a medicament composed of raw materials in the following percentages by weight: 10% to 14% of astragalus roots, 4% to 9% of drynaria, 3% to 8% of an antler glue, 7% to 10% of white peony roots, 6% to 9% of rhizoma polygonati, 3% to 7% of deglued antlers, 3% to 8% of turtle shells, 13% to 20% of fresh fossilia ossis mastodi, 5% to 10% of red sage roots, 3% to 7% of leeches, 4% to 8% of prepared rhizoma cyperi with vinegar, 5% to 10% of hawthorn fruits, 3% to 6% of scutellaria roots and 2% to 4% of licorice roots. The present invention has the advantages that the present invention based on the knowledge of 'bone corrosion' and 'atrophic debility of bones' of Chinese medical science treats the femoral head necrosis in methods of liver and kidney nourishment, vigor replenishment, marrow generation, qi flow and blood circulation promotion, blood stasis expelling and pain alleviation by being combined with the modern pharmacologic research according to the disease cause and the pathogenesis of the 'bone corrosion' and the 'atrophic debility of bones'. The total effective rate of the present invention observed by more than 2000 clinical cases is 92%, and the effectual rate is 68%.
Description
Technical field
The present invention relates to a kind of Chinese medicine, relate to a kind of medicine that is used for the treatment of femur head necrosis specifically.
Background technology
Femur head necrosis is one of clinical difficult disease, is to destroy capital supply of blood flow and the disease that causes by the different causes of disease, and its pathological changes causes the hip joint function forfeiture eventually, and spontaneous remission is rare.This course of disease is long, the disability rate height.Openly do not flow disease journal road though this disease has, divulge according to the relevant expert: the U.S. should increase progressively with 2/10000ths by the disease sickness rate, and domestic sickness rate is 3/10000ths to four.Therapeutic Method has two kinds at present abroad, (one) non-operative treatment: 1, restriction is born a heavy burden.2, hyperbaric oxygen.3, manipulation.4, drug oral or external.But uncertain therapeutic efficacy is cut.(2) operative treatment: 1, decompression.2, bone grafting.3, vascular bundle is implanted in the bone.4, hip replacement.The operation method wound is big, the difficulty height, and indication is limited, and the sclerotin reparation phase is long, has a big risk.
Summary of the invention
Solution of the present invention is based on China's medical science to the card marquis of femur head necrosis and the understanding and the Therapeutic Principle of aspects such as the cause of disease, pathogenesis thereof, achieve with reference to modern pharmacology, from motherland's medicine treasure-house, filter out the homologous natural edible animals and plants of medicated diet, the medicine of developing according to the theory of Chinese medical science prescription that is used for the treatment of femur head necrosis.
Medicine of the present invention is to be made by the raw material of following weight percentage ranges:
The Radix Astragali (or Radix Ginseng, Radix Codonopsis, Radix Pseudostellariae, Radix Panacis Quinquefolii) 10%--14%;
Rhizoma Drynariae (or Herba Epimedii, Radix Dipsaci, parasitism, the Cortex Eucommiae, field dobber, Cordyceps) 4%--9%;
Colla cornus cervi (or Colla Corii Asini, Colla Plastri Testudinis) 3%--8%;
The Radix Paeoniae Alba (or Fructus Corni, Radix Paeoniae Rubra) 7%--10%;
Rhizoma Polygonati (or Radix Rehmanniae, fructus lycii, Fructus Corni, Fructus Ligustri Lucidi, Radix Rehmanniae Preparata, Herba Ecliptae) 6%--9%;
Cornu Cervi Degelatinatum (or Colla Corii Asini, Colla Plastri Testudinis) 3%--7%;
Carapax Trionycis (or Squama Manis, Carapax et Plastrum Testudinis, Endothelium Corneum Gigeriae Galli, Carapax et Plastrum Testudinis, Fructus Liquidambaris, Semen Vaccariae) 3%--8%;
Os Draconis (or Concha Ostreae, dog-leg bone and other animal bone) 13%--20%;
Radix Salviae Miltiorrhizae (or Radix Angelicae Sinensis, Radix Notoginseng, Flos Carthami) 5%--12%;
Hirudo (or Scorpio, eupolyphaga, Pheretima, Sanguis Draxonis, Radix Notoginseng, Flos Carthami, Rhizoma Corydalis) 3%--7%;
Rhizoma Cyperi (processed with vinegar) (or Rhizoma Chuanxiong, Radix Curcumae, rhizoma sparganic, Rhizoma Curcumae) 4%--8%;
Fructus Crataegi (or Massa Medicata Fermentata, Semen Raphani) 5%--10%;
Radix Scutellariae (or Fructus Forsythiae, Cortex Phellodendri, Caulis Lonicerae) 3%-6%;
Radix Glycyrrhizae (or Mel) 2%-4%.
Medicine of the present invention can select following weight percentages to make:
The Radix Astragali 10%; Rhizoma Drynariae 6%; Colla cornus cervi 4%; The Radix Paeoniae Alba 9%; Rhizoma Polygonati 7%; Cornu Cervi Degelatinatum 5%;
Carapax Trionycis 5%; Os Draconis 15%; Radix Salviae Miltiorrhizae 12%; Hirudo 6%; Rhizoma Cyperi (processed with vinegar) 5%; Fructus Crataegi 8%;
Radix Scutellariae 5%; Radix Glycyrrhizae 3%.
Medicine of the present invention also can select following weight percentages to make:
The Radix Astragali 14%; Rhizoma Drynariae 4%; Colla cornus cervi 8%; The Radix Paeoniae Alba 7%; Rhizoma Polygonati 9%; Cornu Cervi Degelatinatum 4%;
Carapax Trionycis 7%; Os Draconis 19%; Radix Salviae Miltiorrhizae 9%; Hirudo 3%; Rhizoma Cyperi (processed with vinegar) 6%; Fructus Crataegi 5%;
Radix Scutellariae 3%; Radix Glycyrrhizae 2%.
Medicine of the present invention also can select following weight percentages to make:
The Radix Astragali 14%; Rhizoma Drynariae 8%; Colla cornus cervi 5%; The Radix Paeoniae Alba 8%; Rhizoma Polygonati 8%; Cornu Cervi Degelatinatum 3%;
Carapax Trionycis 4%; Os Draconis 14%; Radix Salviae Miltiorrhizae 5%; Hirudo 7%; Rhizoma Cyperi (processed with vinegar) 7%; Fructus Crataegi 7%;
Radix Scutellariae 6%; Radix Glycyrrhizae 4%.
Advantage of the present invention just is based on the understanding of motherland's medical science to " osteomyelitis ", " atrophic debility of bones ", according to its cause of disease, pathogenesis, in conjunction with modern pharmacological research, with nourishing the liver and kidney, marrow is given birth in replenishing essence, promoting flow of QI and blood, head necrosis as the method for blood-activating analgetic is treated, osteonecrosis, bone does not connect, osteomyelitis, osteoporosis, immunologic mechanism is low inferior.Example is observed surplus clinical 2000: total effective rate 92%, obvious effective rate 68%.To 1-3 option share head necrosis obvious effective rate 89%, for non-operative treatment has been opened up new road.Through human body and zoopery, determined curative effect is taken for a long time and is had no side effect.This medicine fundamentally changes microcirculation, promote the sclerotin reparation, human body immunity improving power, shorten sclerotin and repair the phase, for early, mid-term patient's non-operative treatment reliable medicine is provided, in, be unfit to do the new road that the patient of operation has opened up a non-operative treatment late period, take simultaneously, easy to carry, and this medicine is to adopt sisters to big compound recipe, wide material sources.
The present invention describes in further detail below in conjunction with specific embodiment:
Embodiment 1:
The first step, choose following weight percentages:
The Radix Astragali 10%; Rhizoma Drynariae 6%; Colla cornus cervi 4%; The Radix Paeoniae Alba 9%; Rhizoma Polygonati 7%; Cornu Cervi Degelatinatum 5%;
Carapax Trionycis 5%; Os Draconis 15%; Radix Salviae Miltiorrhizae 12%; Hirudo 6%; Rhizoma Cyperi (processed with vinegar) 5%; Fructus Crataegi 8%;
Radix Scutellariae 5%; Radix Glycyrrhizae 3%.
In second step, Colla cornus cervi, Cornu Cervi Degelatinatum, Carapax Trionycis, Hirudo, Sanguis Draxonis powder are broken into fine powder cross 100 mesh sieves.
In the 3rd step, it is standby that the Radix Rehmanniae is fried in shallow oil into fluid extract.
The 4th step, all the other each medicines are made fluid extract, make fine powder after the cold drying.
The 5th step, with the raw material mix homogeneously in second step, the 4th step, make clothing with Radix Rehmanniae fluid extract, the watered pill of making the Semen Firmianae size gets final product.
Embodiment 2:
Choose following weight percentages:
The Radix Astragali 14%; Rhizoma Drynariae 4%; Colla cornus cervi 8%; The Radix Paeoniae Alba 7%; Rhizoma Polygonati 9%; Cornu Cervi Degelatinatum 4%;
Carapax Trionycis 7%; Os Draconis 19%; Radix Salviae Miltiorrhizae 9%; Hirudo 3%; Rhizoma Cyperi (processed with vinegar) 6%; Fructus Crataegi 5%;
Radix Scutellariae 3%; Radix Glycyrrhizae 2%.
Preparation method is with embodiment 1.
Embodiment 3:
Choose following weight percentages:
The Radix Astragali 14%; Rhizoma Drynariae 8%; Colla cornus cervi 5%; The Radix Paeoniae Alba 8%; Rhizoma Polygonati 8%; Cornu Cervi Degelatinatum 3%;
Carapax Trionycis 4%; Os Draconis 14%; Radix Salviae Miltiorrhizae 5%; Hirudo 7%; Rhizoma Cyperi (processed with vinegar) 7%; Fructus Crataegi 7%;
Radix Scutellariae 6%; Radix Glycyrrhizae 4%.
Preparation method is with embodiment 1.
Claims (4)
1, a kind of medicine that is used for the treatment of femur head necrosis, it is characterized in that: it is made by the following materials by weight percentage medicine:
Radix Astragali 10%--14%; Rhizoma Drynariae 4%--9%; Colla cornus cervi 3%--8%; Radix Paeoniae Alba 7%--10%; Rhizoma Polygonati 6%--9%; Cornu Cervi Degelatinatum 3%--7%; Carapax Trionycis 3%--8%; Os Draconis 13%--20%; Radix Salviae Miltiorrhizae 5%--12%; Hirudo 3%--7%; Rhizoma Cyperi (processed with vinegar) 4%--8%; Fructus Crataegi 5%--10%; Radix Scutellariae 3%--6%; Radix Glycyrrhizae 2%--4%.
2, the medicine that is used for the treatment of femur head necrosis according to claim 1, it is characterized in that: it is made by the following materials by weight percentage medicine:
The Radix Astragali 10%; Rhizoma Drynariae 6%; Colla cornus cervi 4%; The Radix Paeoniae Alba 9%; Rhizoma Polygonati 7%; Cornu Cervi Degelatinatum 5%; Carapax Trionycis 5%; Os Draconis 15%; Radix Salviae Miltiorrhizae 12%; Hirudo 6%; Rhizoma Cyperi (processed with vinegar) 5%; Fructus Crataegi 8%; Radix Scutellariae 5%; Radix Glycyrrhizae 3%.
3, the medicine that is used for the treatment of femur head necrosis according to claim 1, it is characterized in that: it is made by the following materials by weight percentage medicine:
The Radix Astragali 14%; Rhizoma Drynariae 4%; Colla cornus cervi 8%; The Radix Paeoniae Alba 7%; Rhizoma Polygonati 9%; Cornu Cervi Degelatinatum 4%; Carapax Trionycis 7%; Os Draconis 19%; Radix Salviae Miltiorrhizae 9%; Hirudo 3%; Rhizoma Cyperi (processed with vinegar) 6%; Fructus Crataegi 5%; Radix Scutellariae 3%; Radix Glycyrrhizae 2%.
4, the medicine that is used for the treatment of femur head necrosis according to claim 1, it is characterized in that: it is made by the following materials by weight percentage medicine:
The Radix Astragali 14%; Rhizoma Drynariae 8%; Colla cornus cervi 5%; The Radix Paeoniae Alba 8%; Rhizoma Polygonati 8%; Cornu Cervi Degelatinatum 3%; Carapax Trionycis 4%; Os Draconis 14%; Radix Salviae Miltiorrhizae 5%; Hirudo 7%; Rhizoma Cyperi (processed with vinegar) 7%; Fructus Crataegi 7%; Radix Scutellariae 6%; Radix Glycyrrhizae 4%.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB01106448XA CN1150019C (en) | 2001-01-19 | 2001-01-19 | Medicine for treating hecrosis of femoral head |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB01106448XA CN1150019C (en) | 2001-01-19 | 2001-01-19 | Medicine for treating hecrosis of femoral head |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1319414A CN1319414A (en) | 2001-10-31 |
CN1150019C true CN1150019C (en) | 2004-05-19 |
Family
ID=4655459
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB01106448XA Expired - Fee Related CN1150019C (en) | 2001-01-19 | 2001-01-19 | Medicine for treating hecrosis of femoral head |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1150019C (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100349592C (en) * | 2004-11-26 | 2007-11-21 | 北京长城制药厂 | Chinese medicine composition for treating bone disease, its preparation and use thereof |
CN100350964C (en) * | 2005-04-15 | 2007-11-28 | 杜银华 | Medicine for treating femoral head necrosis and its preparation method |
CN101926906A (en) * | 2010-07-14 | 2010-12-29 | 陈卫衡 | Chinese medicinal composition for treating early and medium femoral necrosis |
CN101926905A (en) * | 2010-07-14 | 2010-12-29 | 陈卫衡 | Application of Chinese medicinal composition containing components for invigorating spleen and reducing phlegm in preparing medicine for treating early and medium stage femoral head necrosis |
CN103142896A (en) * | 2013-03-29 | 2013-06-12 | 刘新宇 | Medicine for treating osteonecrosis of femoral head |
CN106109826A (en) * | 2016-07-29 | 2016-11-16 | 刘宏隆 | A kind of medicine treating femur head necrosis |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101199721B (en) * | 2007-12-14 | 2010-06-09 | 贾心红 | Chinese medicine pill for treating hip necrosis |
CN101317995B (en) * | 2008-07-15 | 2010-07-21 | 张延彬 | Medicament for treating ischemic necrosis of femoral head and preparation method thereof |
CN101590185B (en) * | 2009-04-28 | 2011-03-16 | 吴清玲 | Special Chinese medicinal composition for treating femoral head necrosis, and preparation method thereof |
CN101953941B (en) * | 2010-10-22 | 2011-08-31 | 赵洪社 | Chinese medicinal liquor for treating femoral head necrosis |
CN102028837B (en) * | 2010-12-15 | 2012-07-04 | 孙桂巍 | Method for preparing bone-treatment capsule |
CN102133370B (en) * | 2011-02-24 | 2012-01-04 | 赵玉娟 | Traditional Chinese medicine pelvic inflammatory disease clearing decoction for curing chronic pelvic inflammatory diseases |
CN102178895B (en) * | 2011-04-27 | 2012-03-14 | 胡建忠 | Chinese medicine composition for treating orthopedic disorders and preparation method thereof |
CN102178800B (en) * | 2011-04-28 | 2012-02-29 | 孔建 | Chinese medicine composition for treating rheumatoid arthritis and preparation method thereof |
CN102274415B (en) * | 2011-07-25 | 2013-05-01 | 周新春 | Chinese medicinal composition for treating consumptive disease |
CN102526328B (en) * | 2012-02-21 | 2014-03-12 | 常熟华港制药有限公司 | Medicine for treating bone fracture |
CN102600385A (en) * | 2012-03-03 | 2012-07-25 | 刘天岐 | Lycopodium clavatum pain relieving tablet |
CN102614301B (en) * | 2012-04-12 | 2014-01-29 | 北京阳光一佰生物技术开发有限公司 | Combination for treating bone disease and preparing method |
CN102793849B (en) * | 2012-09-11 | 2013-09-11 | 威海人太生物科技有限公司 | Traditional Chinese medicine for treating middle and old aged osteoporosis |
CN103110798B (en) * | 2013-01-17 | 2014-06-25 | 陈西成 | Chinese medicinal formula for treating menstrual disorder type infertility and preparation method thereof |
CN103007249B (en) * | 2013-01-17 | 2014-07-30 | 赵海荣 | Scar revision ointment |
CN103142795B (en) * | 2013-03-27 | 2014-07-16 | 赵振德 | Traditional Chinese medicinal preparation for treating avascular necrosis of femoral head |
CN104107302A (en) * | 2013-04-20 | 2014-10-22 | 沈阳市骨科医院 | Femoral-head recovering tablet |
CN103349678B (en) * | 2013-07-08 | 2014-12-17 | 孙金堂 | Traditional Chinese medicine composition for treating early-to-mid femoral head necrosis |
CN103417812B (en) * | 2013-08-10 | 2015-03-18 | 山东大学齐鲁医院 | TCM composition for treatment of femoral head necrosis and preparation method thereof |
CN103555531A (en) * | 2013-10-30 | 2014-02-05 | 武汉凌科达科技有限公司 | Production method of health-care bone-strengthening wine |
CN103908563A (en) * | 2014-04-03 | 2014-07-09 | 荆振海 | Traditional Chinese medicine medicament for treating extraskeletal osteosarcoma and preparation method thereof |
CN104173566A (en) * | 2014-08-19 | 2014-12-03 | 杨少辉 | Traditional Chinese medicine granule for treating aseptic necrosis of femoral head |
CN104474128B (en) * | 2014-11-25 | 2018-08-14 | 李楠 | Promoting blood circulation and promoting skeleton formation soup |
CN104435136B (en) * | 2014-12-19 | 2016-08-03 | 重庆希尔安药业有限公司 | A kind of pharmaceutical composition promoting union of fracture and preparation method thereof |
CN104435715A (en) * | 2014-12-22 | 2015-03-25 | 徐晓辉 | Traditional Chinese medicinal liquid for treating avascular necrosis of femoral head |
CN104707074A (en) * | 2015-02-12 | 2015-06-17 | 青岛静康医院 | Traditional Chinese medicine composition for treating avascular necrosis of femoral head and preparation method of traditional Chinese medicine composition |
CN105126032A (en) * | 2015-09-29 | 2015-12-09 | 肖海瑜 | Nursing ointment for recovering postpartum bone fracturing |
CN106390009A (en) * | 2016-05-24 | 2017-02-15 | 张�杰 | Traditional Chinese medicine for treating femur head necrosis |
CN106421237A (en) * | 2016-11-02 | 2017-02-22 | 广西中医药大学附属瑞康医院 | Traditional Chinese medicinal composition as well as preparation method and application thereof |
CN108404038B (en) * | 2017-02-09 | 2020-12-29 | 林畅 | Traditional Chinese medicine composition for treating femoral head ischemic necrosis, warming yang, eliminating turbidity, dredging collaterals and activating bones |
CN107823383A (en) * | 2017-12-04 | 2018-03-23 | 高大朋 | For treating the oral traditional Chinese medicine of caput femoris necrosis |
CN108310191A (en) * | 2018-03-28 | 2018-07-24 | 李兴云 | Promoting blood air circulation and building up bone Chinese medicine composition and its preparation method and application |
CN110302301A (en) * | 2019-05-31 | 2019-10-08 | 西安市红会医院 | A kind of Chinese medicine composition and its application in treatment steroid femur head necrosis |
CN110237171B (en) * | 2019-06-24 | 2022-02-11 | 陈楚翁 | Medicine composition for femoral head necrosis and preparation method and application thereof |
CN110613780A (en) * | 2019-10-21 | 2019-12-27 | 屈本喜 | Traditional Chinese medicine pill for treating femoral head necrosis and preparation method |
CN114224991B (en) * | 2022-01-21 | 2022-11-29 | 肖涟波 | Traditional Chinese medicine composition for treating early and medium hormonal femoral head necrosis and application thereof |
-
2001
- 2001-01-19 CN CNB01106448XA patent/CN1150019C/en not_active Expired - Fee Related
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100349592C (en) * | 2004-11-26 | 2007-11-21 | 北京长城制药厂 | Chinese medicine composition for treating bone disease, its preparation and use thereof |
CN100350964C (en) * | 2005-04-15 | 2007-11-28 | 杜银华 | Medicine for treating femoral head necrosis and its preparation method |
CN101926906A (en) * | 2010-07-14 | 2010-12-29 | 陈卫衡 | Chinese medicinal composition for treating early and medium femoral necrosis |
CN101926905A (en) * | 2010-07-14 | 2010-12-29 | 陈卫衡 | Application of Chinese medicinal composition containing components for invigorating spleen and reducing phlegm in preparing medicine for treating early and medium stage femoral head necrosis |
CN101926906B (en) * | 2010-07-14 | 2011-09-07 | 陈卫衡 | Chinese medicinal composition for treating early and medium femoral necrosis |
CN101926905B (en) * | 2010-07-14 | 2011-09-14 | 陈卫衡 | Application of Chinese medicinal composition containing components for invigorating spleen and reducing phlegm in preparing medicine for treating early and medium stage femoral head necrosis |
CN103142896A (en) * | 2013-03-29 | 2013-06-12 | 刘新宇 | Medicine for treating osteonecrosis of femoral head |
CN103142896B (en) * | 2013-03-29 | 2014-08-06 | 刘新宇 | Medicine for treating osteonecrosis of femoral head |
CN106109826A (en) * | 2016-07-29 | 2016-11-16 | 刘宏隆 | A kind of medicine treating femur head necrosis |
CN106109826B (en) * | 2016-07-29 | 2019-11-01 | 刘宏隆 | A kind of drug for treating caput femoris necrosis |
Also Published As
Publication number | Publication date |
---|---|
CN1319414A (en) | 2001-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1150019C (en) | Medicine for treating hecrosis of femoral head | |
CN1162171C (en) | Gynopathy treating traditional Chinese medicine | |
CN1298346C (en) | Dynamic medicine for channels and collaterals and blood vessel | |
CN1682982A (en) | A Chinese medicinal pill for treating chronic nephropathy and renal insufficiency | |
CN1899479A (en) | Chinese medicine compound preparation for treating osteoporosis after menopause and its preparation | |
CN1059113C (en) | Multi-effect nutrient health care medicinal liquor prescription for old and middle-aged people and preparation process thereof | |
CN1284567C (en) | Medicinal liquid for treating osteoporosis and its preparation method | |
CN103110762A (en) | Traditional Chinese medicine composition for treating old fracture | |
CN1061884C (en) | Chinese medicine for ischemic necrosis of thighbone head | |
CN1049827C (en) | Anti-cancer powder | |
CN1506098A (en) | Medicine composition for treating liver fibrillation and liver cirrhosis and its prepn process | |
CN103611100A (en) | Traditional Chinese medicine for treating toothaches | |
CN1086144C (en) | Capsule for tonifying kidney | |
GB2402062A (en) | Pharmaceutical composition for the prophylaxis or treatment of osteoporosis | |
CN1285378C (en) | Nourishing wine for regulating human body balance function | |
CN1422649A (en) | Chinese medicine proprietary for treating cerebrovascular and cardiovascular disease | |
CN1365822A (en) | 'Shugan Lidan' capsule and its preparing process | |
CN104800443A (en) | Bone setting agent with functions of tonifying kidney and regenerating bone marrow | |
CN104857441A (en) | Oral preparation for treating femoral head necrosis and preparation method of oral preparation | |
CN1129444C (en) | Antiabortifacient for treating acyesis and sterility and its preparing process | |
CN109876127A (en) | A kind of blood-nourishing angelica capsules and preparation method thereof | |
CN1176108A (en) | Kidney-warming and Yang-activating medicine | |
CN1124143C (en) | Pregnancy promoting medicine for treating hyperprolactinemia sterility and its preparation | |
CN1387903A (en) | Cardiac and cerebral blood vessel nourishing tea | |
CN114224991B (en) | Traditional Chinese medicine composition for treating early and medium hormonal femoral head necrosis and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C06 | Publication | ||
PB01 | Publication | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20040519 Termination date: 20180119 |